Efficacy of Pfizer-BioNTech COVID-19 Vaccine Varies by DMT, Study Finds

Efficacy of Pfizer-BioNTech COVID-19 Vaccine Varies by DMT, Study Finds

294865

Efficacy of Pfizer-BioNTech COVID-19 Vaccine Varies by DMT, Study Finds

Are you being treated with a disease-modifying therapy (DMT) and wondering how it might affect the efficacy of an mRNA-based COVID-19 vaccine? If so, a recent study may provide some clarity. The study, published in Therapeutic Advances in Neurological Disorders, looked at 125 MS patients either being treated with cladribine, ocrelizumab, or fingolimod, or no DMT. A control group of healthy people also was included. Study participants were tested 4.5 to 6.5 weeks after receiving…

You must be logged in to read/download the full post.